Literature DB >> 23486169

Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils.

Yun Zhou1, Kejing Song, Richard G Painter, Martha Aiken, Jakob Reiser, Bruce A Stanton, William M Nauseef, Guoshun Wang.   

Abstract

Optimal microbicidal activity of human polymorphonuclear leukocytes (PMN) relies on the generation of toxic agents such as hypochlorous acid (HOCl) in phagosomes. HOCl formation requires H2O2 produced by the NADPH oxidase, myeloperoxidase derived from azurophilic granules, and chloride ion. Chloride transport from cytoplasm into phagosomes requires chloride channels which include cystic fibrosis transmembrane conductance regulator (CFTR), a cAMP-activated chloride channel. However, the phagosomal targeting of CFTR in PMN has not been defined. Using human peripheral blood PMN, we determined that 95-99% of lysosomal-associated membrane protein 1 (LAMP-1)-positive mature phagosomes were CFTR positive, as judged by immunostaining and flow cytometric analysis. To establish a model cell system to evaluate CFTR phagosomal recruitment, we stably expressed enhanced green fluorescent protein (EGFP) alone, EGFP-wt-CFTR and EGFP-DF508-CFTR fusion proteins in promyelocytic PLB-985 cells, respectively. After differentiation into neutrophil-like cells, CFTR presentation to phagosomes was examined. EGFP-wt-CFTR was observed to associate with phagosomes and colocalize with LAMP-1. Flow cytometric analysis of the isolated phagosomes indicated that such a phagosomal targeting was determined by the CFTR portion of the fusion protein. In contrast, significantly less EGFP-DF508-CFTR was found in phagosomes, indicating a defective targeting of the molecule to the organelle. Importantly, the CFTR corrector compound VRT-325 facilitated the recruitment of DF508-CFTR to phagosomes. These data demonstrate the possibility of pharmacologic correction of impaired recruitment of mutant CFTR, thereby providing a potential means to augment chloride supply to the phagosomes of PMN in patients with cystic fibrosis to enhance their microbicidal function.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486169      PMCID: PMC3717385          DOI: 10.1159/000346568

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  39 in total

1.  Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8.

Authors:  C Taggart; R J Coakley; P Greally; G Canny; S J O'Neill; N G McElvaney
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

2.  Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans.

Authors:  Yasuaki Aratani; Fumiaki Kura; Haruo Watanabe; Hisayoshi Akagawa; Yukie Takano; Akiko Ishida-Okawara; Kazuo Suzuki; Nobuyo Maeda; Hideki Koyama
Journal:  J Med Microbiol       Date:  2006-09       Impact factor: 2.472

3.  Direct measurement of free chloride concentrations in the phagolysosomes of human neutrophils.

Authors:  Richard G Painter; Guoshun Wang
Journal:  Anal Chem       Date:  2006-05-01       Impact factor: 6.986

4.  Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase.

Authors:  Y Aratani; F Kura; H Watanabe; H Akagawa; Y Takano; K Suzuki; N Maeda; H Koyama
Journal:  J Infect Dis       Date:  2000-09-06       Impact factor: 5.226

Review 5.  Myeloperoxidase: friend and foe.

Authors:  Seymour J Klebanoff
Journal:  J Leukoc Biol       Date:  2005-02-02       Impact factor: 4.962

6.  CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis.

Authors:  Richard G Painter; Vincent G Valentine; Nicholas A Lanson; Kevin Leidal; Qiang Zhang; Gisele Lombard; Connie Thompson; Anand Viswanathan; William M Nauseef; Guangdi Wang; Guoshun Wang
Journal:  Biochemistry       Date:  2006-08-29       Impact factor: 3.162

7.  Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes.

Authors:  S J Klebanoff
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

8.  GFP-tagged CFTR transgene is functional in the G551D cystic fibrosis mouse colon.

Authors:  D Oceandy; B McMorran; R Schreiber; B J Wainwright; K Kunzelmann
Journal:  J Membr Biol       Date:  2003-04-01       Impact factor: 1.843

9.  The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.

Authors:  Marcus Mall; Silvia M Kreda; April Mengos; Timothy J Jensen; Stephanie Hirtz; Hans H Seydewitz; James Yankaskas; Karl Kunzelmann; John R Riordan; Richard C Boucher
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

Review 10.  Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?

Authors:  V Witko-Sarsat; I Sermet-Gaudelus; G Lenoir; B Descamps-Latscha
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more
  25 in total

Review 1.  Salt, chloride, bleach, and innate host defense.

Authors:  Guoshun Wang; William M Nauseef
Journal:  J Leukoc Biol       Date:  2015-06-05       Impact factor: 4.962

Review 2.  Myeloperoxidase in human neutrophil host defence.

Authors:  William M Nauseef
Journal:  Cell Microbiol       Date:  2014-06-19       Impact factor: 3.715

3.  Novel insights related to CF neutrophils.

Authors:  Silvia M Uriarte
Journal:  Blood       Date:  2014-08-14       Impact factor: 22.113

Review 4.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

5.  Synthetic secoisolariciresinol diglucoside (LGM2605) inhibits myeloperoxidase activity in inflammatory cells.

Authors:  Om P Mishra; Anatoliy V Popov; Ralph A Pietrofesa; Eiko Nakamaru-Ogiso; Mark Andrake; Melpo Christofidou-Solomidou
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-07       Impact factor: 3.770

6.  Neutrophils, from cradle to grave and beyond.

Authors:  William M Nauseef
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

7.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

8.  Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.

Authors:  Mia F Tazi; Duaa A Dakhlallah; Kyle Caution; Madelyn M Gerber; Sheng-Wei Chang; Hany Khalil; Benjamin T Kopp; Amr E Ahmed; Kathrin Krause; Ian Davis; Clay Marsh; Amy E Lovett-Racke; Larry S Schlesinger; Estelle Cormet-Boyaka; Amal O Amer
Journal:  Autophagy       Date:  2016-11       Impact factor: 16.016

Review 9.  Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.

Authors:  Xiaoqing Guan; Yuning Hou; Fei Sun; Zhe Yang; Chunying Li
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

10.  Neutrophil dysfunction in cystic fibrosis.

Authors:  Lael M Yonker; Anika Marand; Sinan Muldur; Alex Hopke; Hui Min Leung; Denis De La Flor; Grace Park; Hanna Pinsky; Lauren B Guthrie; Guillermo J Tearney; Daniel Irimia; Bryan P Hurley
Journal:  J Cyst Fibros       Date:  2021-02-13       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.